Superstring Capital Management manages investment portfolios for its hedge funds and private equity funds. The firm focuses on long and short public equity and private investments in healthcare companies with operations or opportunities in the China market. Superstring uses a fundamental, long-term investment approach, leveraging its knowledge of industry dynamics and the regulatory framework within the China healthcare ecosystem. The firm's clients are qualified investors in the United States and elsewhere.
Fee Structure
Superstring Capital Management manages investments for hedge funds and a separately managed account. The annual management fee ranges from 1.0% to 2.0% of the fund's assets, depending on the share class. This fee is deducted quarterly in advance. The management fee may be waived or modified for certain investors, such as members, employees, or affiliates of Superstring, relatives of such persons, or for certain large or strategic investors.